ONCOLIX
Oncolix is a clinical-stage biotechnology company that is focused on cancer. The company is currently conducting a Phase I clinical trial for the indication of ovarian cancer. The drug, Prolanta, is a prolactin receptor antagonist. The mechanism of action is autophagocytosis or autophagy.
ONCOLIX
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2007-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.oncolixbio.com
Total Employee:
11+
Status:
Active
Contact:
9182533295
Email Addresses:
[email protected]
Total Funding:
8.46 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Mobile Non Scaleable Content Nginx CloudFront Google Adsense AWS Global Accelerator AdBlock Acceptable Ads
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Somanta Pharmaceuticals
Somanta Pharmaceuticals is a development-stage biopharmaceutical company manufacturing therapeutic drugs for the treatment of cancer.
Current Employees Featured
